Literature DB >> 30377998

Cardiac sarcoidosis with complete metabolic response and resolution of left ventricular dysfunction complicated by subsequent VT storm.

J See1,2, R Sharma3, K Wechalekar3.   

Abstract

Sarcoidosis is a multisystem granulomatous disease of unknown aetiology that involves primarily the lungs and lymph nodes. Cardiac involvement is less common but associated with a poorer prognosis. With contemporary diagnostic modalities such as cardiac magnetic resonance and fluorine-18-fluoro-deoxy-glucose positron emission tomography computed tomography, cardiac involvement in sarcoidosis is increasingly diagnosed with appropriate therapy improving outcomes. Although steroid therapy may be protective or therapeutic in preventing left ventricular scarring and preserving LV function, it may not be as effective in the late stages of disease. (Chiu et al in Am J Cardiol 95:143-146, 2005) We present a case of cardiac sarcoidosis with significantly impaired ejection fraction that was diagnosed late in the course of disease with complete metabolic response to therapy and an improvement of LV function, but with a subsequent complication of ventricular tachycardia storm.

Entities:  

Keywords:  PET; Sarcoid heart disease; molecular imaging

Mesh:

Year:  2018        PMID: 30377998     DOI: 10.1007/s12350-018-01486-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  4 in total

1.  Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis.

Authors:  Chiung-Zuan Chiu; Satoshi Nakatani; Guican Zhang; Teruo Tachibana; Fumio Ohmori; Masakazu Yamagishi; Masafumi Kitakaze; Hitonobu Tomoike; Kunio Miyatake
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

Review 2.  Hibernating myocardium.

Authors:  W Wijns; S F Vatner; P G Camici
Journal:  N Engl J Med       Date:  1998-07-16       Impact factor: 91.245

3.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

Authors:  David H Birnie; William H Sauer; Frank Bogun; Joshua M Cooper; Daniel A Culver; Claire S Duvernoy; Marc A Judson; Jordana Kron; Davendra Mehta; Jens Cosedis Nielsen; Amit R Patel; Tohru Ohe; Pekka Raatikainen; Kyoko Soejima
Journal:  Heart Rhythm       Date:  2014-05-09       Impact factor: 6.343

4.  Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation.

Authors:  Saurabh Kumar; Chirag Barbhaiya; Koichi Nagashima; Eue-Keun Choi; Laurence M Epstein; Roy M John; Melanie Maytin; Christine M Albert; Amy L Miller; Bruce A Koplan; Gregory F Michaud; Usha B Tedrow; William G Stevenson
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-19
  4 in total
  1 in total

1.  Preparation is everything: The impact of a structured preparation protocol on cardiac 18F-FDG PET imaging for cardiac sarcoidosis.

Authors:  Sanjay Divakaran; Michael T Osborne
Journal:  J Nucl Cardiol       Date:  2019-06-27       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.